CDC advisory panel: senior need Prevnar 12 and Pneumovax 23
the ONA take:
According to a revised vaccination schedule recommended by the 2015 Advisory Committee on Immunization Practices (ACIP), adults 65 years and older need two pneumococcal vaccines to better protect them against a pneumococcal infection that could lead to pneumonia, meningitis, or sepsis.
Older people are at increased risk for developing a life-threatening infection by pneumococcal bacteria. Specifically, older adults are at a nearly 10 times increased risk of invasive pneumococcal disease compared with young adults.
ACIP, which is the vaccine advisory panel for the U.S. Centers for Disease Control and Prevention (CDC), recommends that people 65 years and older should receive both the Prevnar 13 and Pneumovax 23 vaccines.
Prevnar provides protection against 13 types of pneumococcal bacteria, while Pneumovax 23 protects against 23 types. The panel says that rather than only getting the vaccine that covers more types, getting both seems to provide broader protection as the two vaccines work in different ways.
If patients agree to get both vaccines, Prevnar 12 should be given first with Pneumovax 23 given 12 months later.
If a patients has already received Pneumovax 23, then the patient can receive Prevnar 12 12 months later. Because these recommendations come from the CDC's ACIP, health insurance companies, including Medicare, should cover both vaccinations for patients.
Two pneumococcal vaccines to better protect them against an infection that could lead to pneumonia, meningitis, or sepsis.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|